2006. ISPOR European Congress – Cost-Effectiveness of Fulvestrant as an Additional Endocrine Step in the Treatment Sequence for Hormone Responsive Advanced Breast Cancer

Hirsch M, Gait C, Chambers J. Cost-Effectiveness of Fulvestrant as an Additional Endocrine Step in the Treatment Sequence for Hormone Responsive Advanced Breast Cancer. Value Health. 2006 Nov-Dec;9(6):A288. Presented at: ISPOR 9th Annual European Congress; October 28-31, 2006; Copenhagen, Denmark.